Form 4: OptimizeRx Corp: Chief Commercial Officer Theresa Greco Reports Stock and Option Grants

Theresa Greco, Chief Commercial Officer of OptimizeRx Corp, reports the acquisition of restricted stock units and stock options.

Summary

• Theresa Greco, Chief Commercial Officer of OptimizeRx Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 15, 2025, Ms. Greco was granted 2,441 restricted stock units that will vest on May 15, 2026.
• She also received 7,042 restricted stock units that will vest in three equal annual installments beginning on May 15, 2026.
• Additionally, Ms. Greco was granted a stock option for 12,133 shares with an exercise price of $10.65, vesting in three equal annual installments beginning May 15, 2026.
• Following these transactions, Ms. Greco beneficially owns 60,356 shares of common stock and holds options for 12,133 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The filing reflects standard executive compensation practices, indicating confidence in the company's future performance. The grants align management's interests with shareholders.

Positives

• The grant of restricted stock units and stock options aligns Ms. Greco's interests with those of the shareholders.
• The vesting schedules incentivize continued service and contribution to the company's success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and alignment with shareholder interests.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are a common form of executive compensation in the technology and healthcare industries, used to attract and retain talent.
• Vesting schedules are typically structured over a 3-4 year period to incentivize long-term commitment, which aligns with the vesting schedule outlined in the document.

Stakeholder Impact

• The grants align the executive's interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Form 4, beneficial ownership, restricted stock units, stock options, OPRX, OptimizeRx Corp, Theresa Greco, Chief Commercial Officer